627 related articles for article (PubMed ID: 12140465)
1. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity.
Chamlin SL; Kao J; Frieden IJ; Sheu MY; Fowler AJ; Fluhr JW; Williams ML; Elias PM
J Am Acad Dermatol; 2002 Aug; 47(2):198-208. PubMed ID: 12140465
[TBL] [Abstract][Full Text] [Related]
2. Changes of antimicrobial peptides and transepidermal water loss after topical application of tacrolimus and ceramide-dominant emollient in patients with atopic dermatitis.
Park KY; Kim DH; Jeong MS; Li K; Seo SJ
J Korean Med Sci; 2010 May; 25(5):766-71. PubMed ID: 20436715
[TBL] [Abstract][Full Text] [Related]
3. Acceptability and efficacy of an emollient containing ceramide-precursor lipids and moisturizing factors for atopic dermatitis in pediatric patients.
Hon KL; Pong NH; Wang SS; Lee VW; Luk NM; Leung TF
Drugs R D; 2013 Mar; 13(1):37-42. PubMed ID: 23456759
[TBL] [Abstract][Full Text] [Related]
4. A new moisturizer containing physiologic lipid granules alleviates atopic dermatitis.
Na JI; Hwang JS; Park HJ; Kim DH; Park WS; Youn SW; Huh CH; Park KC
J Dermatolog Treat; 2010 Jan; 21(1):23-7. PubMed ID: 19626524
[TBL] [Abstract][Full Text] [Related]
5. Moisturizers versus Current and Next-Generation Barrier Repair Therapy for the Management of Atopic Dermatitis.
Elias PM; Wakefield JS; Man MQ
Skin Pharmacol Physiol; 2019; 32(1):1-7. PubMed ID: 30336483
[TBL] [Abstract][Full Text] [Related]
6. Placebo-controlled, double-blind, randomized, prospective study of a glycerol-based emollient on eczematous skin in atopic dermatitis: biophysical and clinical evaluation.
Breternitz M; Kowatzki D; Langenauer M; Elsner P; Fluhr JW
Skin Pharmacol Physiol; 2008; 21(1):39-45. PubMed ID: 18025807
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a paraffin-based moisturizer compared to a ceramide-based moisturizer in children with atopic dermatitis: A double-blind, randomized controlled trial.
Gupta S; Ramam M; Sharma VK; Sethuraman G; Pandey RM; Bhari N
Pediatr Dermatol; 2023; 40(4):627-632. PubMed ID: 37269189
[TBL] [Abstract][Full Text] [Related]
8. Testing the Actions of a Multi-action Emollient: Patient's Acceptability Determines Product Efficacy.
Hon KL; Kung JSC; Tsang KYC; Yu JWS; Lee VW; Leung TF
Curr Pediatr Rev; 2018; 14(2):110-116. PubMed ID: 29149811
[TBL] [Abstract][Full Text] [Related]
9. Improvement of skin barrier function in atopic dermatitis patients with a new moisturizer containing a ceramide precursor.
Simpson E; Böhling A; Bielfeldt S; Bosc C; Kerrouche N
J Dermatolog Treat; 2013 Apr; 24(2):122-5. PubMed ID: 22812593
[TBL] [Abstract][Full Text] [Related]
10. Randomized, double-blind, split-side, comparison study of moisturizer containing licochalcone A and 1% hydrocortisone in the treatment of childhood atopic dermatitis.
Wananukul S; Chatproedprai S; Chunharas A; Limpongsanuruk W; Singalavanija S; Nitiyarom R; Wisuthsarewong W
J Med Assoc Thai; 2013 Sep; 96(9):1135-42. PubMed ID: 24163988
[TBL] [Abstract][Full Text] [Related]
11. Clinical use of a ceramide-based moisturizer for treating dogs with atopic dermatitis.
Jung JY; Nam EH; Park SH; Han SH; Hwang CY
J Vet Sci; 2013; 14(2):199-205. PubMed ID: 23814473
[TBL] [Abstract][Full Text] [Related]
12. An over-the-counter moisturizer is as clinically effective as, and more cost-effective than, prescription barrier creams in the treatment of children with mild-to-moderate atopic dermatitis: a randomized, controlled trial.
Miller DW; Koch SB; Yentzer BA; Clark AR; O'Neill JR; Fountain J; Weber TM; Fleischer AB
J Drugs Dermatol; 2011 May; 10(5):531-7. PubMed ID: 21533301
[TBL] [Abstract][Full Text] [Related]
13. Clinical Effectiveness of Moisturizers in Atopic Dermatitis and Related Disorders: A Systematic Review.
Lindh JD; Bradley M
Am J Clin Dermatol; 2015 Oct; 16(5):341-59. PubMed ID: 26267423
[TBL] [Abstract][Full Text] [Related]
14. Patient acceptability, efficacy, and skin biophysiology of a cream and cleanser containing lipid complex with shea butter extract versus a ceramide product for eczema.
Hon KL; Tsang YC; Pong NH; Lee VW; Luk NM; Chow CM; Leung TF
Hong Kong Med J; 2015 Oct; 21(5):417-25. PubMed ID: 26314567
[TBL] [Abstract][Full Text] [Related]
15. Treatment of atopic dermatitis with KAM-3008, a barrier-based, non-steroidal topical cream.
Bomstein Y; Rozenblat S
J Dermatolog Treat; 2015 Oct; 26(5):426-30. PubMed ID: 25893370
[TBL] [Abstract][Full Text] [Related]
16. Barrier repair therapy in atopic dermatitis: an overview.
Hon KL; Leung AK; Barankin B
Am J Clin Dermatol; 2013 Oct; 14(5):389-99. PubMed ID: 23757122
[TBL] [Abstract][Full Text] [Related]
17. The objective severity assessment of atopic dermatitis score: an objective measure using permeability barrier function and stratum corneum hydration with computer-assisted estimates for extent of disease.
Sugarman JL; Fluhr JW; Fowler AJ; Bruckner T; Diepgen TL; Williams ML
Arch Dermatol; 2003 Nov; 139(11):1417-22. PubMed ID: 14623701
[TBL] [Abstract][Full Text] [Related]
18. Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders.
Lodén M
Am J Clin Dermatol; 2003; 4(11):771-88. PubMed ID: 14572299
[TBL] [Abstract][Full Text] [Related]
19. Different types of emollient cream exhibit diverse physiological effects on the skin barrier in adults with atopic dermatitis.
Danby SG; Andrew PV; Taylor RN; Kay LJ; Chittock J; Pinnock A; Ulhaq I; Fasth A; Carlander K; Holm T; Cork MJ
Clin Exp Dermatol; 2022 Jun; 47(6):1154-1164. PubMed ID: 35167133
[TBL] [Abstract][Full Text] [Related]
20. A look at epidermal barrier function in atopic dermatitis: physiologic lipid replacement and the role of ceramides.
Sajić D; Asiniwasis R; Skotnicki-Grant S
Skin Therapy Lett; 2012 Jul; 17(7):6-9. PubMed ID: 22825649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
